Anatomy and Cell Biology

Korean Association of Anatomists (대한해부학회)
권호 표지
DOI QR코드

DOI QR Code

The expression of corticotropin-releasing factor and its receptors in the spinal cord and dorsal root ganglion in a rat model of neuropathic pain

  • Kim, Eun-Hyun (Department of Anatomy and Cell Biology, College of Medicine, Hanyang University) ;
  • Ryu, Da-Hye (Department of Anatomy and Cell Biology, College of Medicine, Hanyang University) ;
  • Hwang, Se-Jin (Department of Anatomy and Cell Biology, College of Medicine, Hanyang University)
  • Published : 2011.03.31
⟨ Previous Next ⟩

Abstract

Corticotropin-releasing factor (CRF) is a peptide involved in the activation of the hypothalamic-pituitary-adrenal (HPA) axis. CRF is distributed not only along the HPA axis but also throughout pain-relevant anatomical sites. CRF elicits potent antinociception at the three main levels of pain transmissions: namely, the brain, spinal cord, and peripheral sensory neurons. The widespread distribution of CRF receptors 1 and 2 in the brain offers several targets wherein CRF could alter pain, some of which may be independent of the HPA axis. In this study, we assessed the expression of CRF and its receptors, CRF receptor type (CRFR)1 and CRFR2, in the spinal dorsal horn and dorsal root ganglion (DRG) in a rat model of neuropathic pain induced by spinal nerve injury (SNI). CRF was expressed in a few DRG neurons and primary afferent fibers in the dorsal horns of na$\ddot{i}$ve rats, and the CRF-positive neurons in DRG and fibers in the spinal dorsal horn were found to have increased after SNI. CRFR1 was not expressed in DRG or the dorsal horn and CRFR2 was expressed weakly in the small neurons in DRG in the na$\ddot{u}$ve rats. After SNI, CRFR1 was expressed in the activated microglia in the ipsilateral dorsal horn, and immunoreaction for CRFR2 was increased in the contralateral DRG following SNI. Consequently, it has been suggested that the increased expression of CRF and CRFR2 in DRG neurons and primary afferent fibers in dorsal horn, and CRFR1 in the activated microglia, may be involved in the mediation of stress responses as well as in microglial activation in the neuropathic pain state following SNI.

Keywords

References

  1. Perrin MH, Sutton SW, Cervini LA, Rivier JE, Vale WW. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors. J Pharmacol Exp Ther 1999;288:729-34.
  2. Perrin MH, Vale WW. Corticotropin releasing factor receptors and their ligand family. Ann N Y Acad Sci 1999;885:312-28.
  3. Emeric-Sauval E. Corticotropin-releasing factor (CRF): a review. Psychoneuroendocrinology 1986;11:277-94. https://doi.org/10.1016/0306-4530(86)90014-4
  4. Olschowka JA, O'Donohue TL, Mueller GP, Jacobowitz DM. The distribution of corticotropin releasing factor-like immunoreactive neurons in rat brain. Peptides 1982;3:995-1015. https://doi.org/10.1016/0196-9781(82)90071-7
  5. Merchenthaler I, Hynes MA, Vigh S, Shally AV, Petrusz P. Immunocytochemical localization of corticotropin releasing factor (CRF) in the rat spinal cord. Brain Res 1983;275:373-7. https://doi.org/10.1016/0006-8993(83)91001-6
  6. Skofitsch G, Zamir N, Helke CJ, Savitt JM, Jacobowitz DM. Corticotropin releasing factor-like immunoreactivity in sensory ganglia and capsaicin sensitive neurons of the rat central nervous system: colocalization with other neuropeptides. Peptides 1985;6:307-18. https://doi.org/10.1016/0196-9781(85)90057-9
  7. Kawatani M, Suzuki T, de Groat WC. Corticotropin releasing factor-like immunoreactivity in afferent projections to the sacral spinal cord of the cat. J Auton Nerv Syst 1996;61:218-26. https://doi.org/10.1016/S0165-1838(96)00083-5
  8. De Souza EB. Corticotropin-releasing factor receptors in the rat central nervous system: characterization and regional distribution. J Neurosci 1987;7:88-100.
  9. Bell JA, de Souza EB. Functional corticotropin-releasing factor receptors in neonatal rat spinal cord. Peptides 1988;9:1317-22. https://doi.org/10.1016/0196-9781(88)90198-2
  10. Lariviere WR, Melzack R. The role of corticotropin-releasing factor in pain and analgesia. Pain 2000;84:1-12. https://doi.org/10.1016/S0304-3959(99)00193-1
  11. Amit Z, Galina ZH. Stress-induced analgesia: adaptive pain suppression. Physiol Rev 1986;66:1091-120.
  12. Mousa SA, Bopaiah CP, Richter JF, Yamdeu RS, Schafer M. Inhibition of inflammatory pain by CRF at peripheral, spinal and supraspinal sites: involvement of areas coexpressing CRF receptors and opioid peptides. Neuropsychopharmacology 2007;32:2530-42. https://doi.org/10.1038/sj.npp.1301393
  13. Ji G, Neugebauer V. Differential effects of CRF1 and CRF2 receptor antagonists on pain-related sensitization of neurons in the central nucleus of the amygdala. J Neurophysiol 2007;97:3893-904. https://doi.org/10.1152/jn.00135.2007
  14. Fu Y, Neugebauer V. Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior. J Neurosci 2008;28:3861-76. https://doi.org/10.1523/JNEUROSCI.0227-08.2008
  15. Studeny S, Vizzard MA. Corticotropin-releasing factor (CRF) expression in postnatal and adult rat sacral parasympathetic nucleus (SPN). Cell Tissue Res 2005;322:339-52. https://doi.org/10.1007/s00441-005-0014-2
  16. Korosi A, Kozicz T, Richter J, Veening JG, Olivier B, Roubos EW. Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord. J Comp Neurol 2007;502:973-89. https://doi.org/10.1002/cne.21347
  17. Sengupta JN. Visceral pain: the neurophysiological mechanism. Handb Exp Pharmacol 2009;(194):31-74.
  18. Cabot PJ. Immune-derived opioids and peripheral antinociception. Clin Exp Pharmacol Physiol 2001;28:230-2. https://doi.org/10.1046/j.1440-1681.2001.03425.x
  19. Ock J, Lee H, Kim S, Lee WH, Choi DK, Park EJ, Kim SH, Kim IK, Suk K. Induction of microglial apoptosis by corticotropin-releasing hormone. J Neurochem 2006;98:962-72. https://doi.org/10.1111/j.1471-4159.2006.03933.x
  20. Narita M, Yoshida T, Nakajima M, Narita M, Miyatake M, Takagi T, Yajima Y, Suzuki T. Direct evidence for spinal cord microglia in the development of a neuropathic pain-like state in mice. J Neurochem 2006;97:1337-48. https://doi.org/10.1111/j.1471-4159.2006.03808.x
  21. Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992;50:355-63. https://doi.org/10.1016/0304-3959(92)90041-9
  22. Lee SE, Kim JH. Involvement of substance P and calcitonin gene-related peptide in development and maintenance of neuropathic pain from spinal nerve injury model of rat. Neurosci Res 2007;58:245-9. https://doi.org/10.1016/j.neures.2007.03.004
  23. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994;53:55-63. https://doi.org/10.1016/0165-0270(94)90144-9
  24. Ikeda H, Kusudo K, Ryu PD, Murase K. Effects of corticotropin-releasing factor on plasticity of optically recorded neuronal activity in the substantia gelatinosa of rat spinal cord slices. Pain 2003;106:197-207. https://doi.org/10.1016/j.pain.2003.08.004
  25. Gillardon F, Klimaschewski L, Wickert H, Krajewski S, Reed JC, Zimmermann M. Expression pattern of candidate cell death effector proteins Bax, Bcl-2, Bcl-X, and c-Jun in sensory and motor neurons following sciatic nerve transection in the rat. Brain Res 1996;739:244-50. https://doi.org/10.1016/S0006-8993(96)00829-3
  26. Zimmermann M. Pathobiology of neuropathic pain. Eur J Pharmacol 2001;429:23-37. https://doi.org/10.1016/S0014-2999(01)01303-6
  27. Du F, Yin L, Shi M, Cheng H, Xu X, Liu Z, Zhang G, Wu Z, Feng G, Zhao G. Involvement of microglial cells in infrasonic noise-induced stress via upregulated expression of corticotrophin releasing hormone type 1 receptor. Neuroscience 2010;167:909-19. https://doi.org/10.1016/j.neuroscience.2010.02.060
  28. Stevens SL, Shaw TE, Dykhuizen E, Lessov NS, Hill JK, Wurst W, Stenzel-Poore MP. Reduced cerebral injury in CRH-R1 deficient mice after focal ischemia: a potential link to microglia and atrocytes that express CRH-R1. J Cereb Blood Flow Metab 2003;23:1151-9.
  29. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996;19:312-8. https://doi.org/10.1016/0166-2236(96)10049-7
  30. Hains BC, Waxman SG. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J Neurosci 2006;26:4308-17. https://doi.org/10.1523/JNEUROSCI.0003-06.2006
  31. Schreiber KL, Beitz AJ, Wilcox GL. Activation of spinal microglia in a murine model of peripheral inflammation-induced, long-lasting contralateral allodynia. Neurosci Lett 2008;440:63-7. https://doi.org/10.1016/j.neulet.2008.05.044
  32. Ledeboer A, Sloane EM, Milligan ED, Frank MG, Mahony JH, Maier SF, Watkins LR. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 2005;115:71-83. https://doi.org/10.1016/j.pain.2005.02.009
  33. Festoff BW, Ameenuddin S, Arnold PM, Wong A, Santacruz KS, Citron BA. Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury. J Neurochem 2006;97:1314-26. https://doi.org/10.1111/j.1471-4159.2006.03799.x

Cited by

  1. Corticotropin-releasing factor mediates bone cancer induced pain through neuronal activation in rat spinal cord vol.36, pp.12, 2011, https://doi.org/10.1007/s13277-015-3670-1
  2. Differential Transcriptional Profiling of Damaged and Intact Adjacent Dorsal Root Ganglia Neurons in Neuropathic Pain vol.10, pp.4, 2011, https://doi.org/10.1371/journal.pone.0123342
  3. Hypothalamic-pituitary-adrenal axis function in traumatic spinal cord injury-related neuropathic pain: a case-control study vol.42, pp.8, 2011, https://doi.org/10.1007/s40618-019-1002-9
  4. Small-Molecule Ligands as Challenge for Positron Emission Tomography of Peptide Receptors in Neurons and Microglia of the Brain vol.9, pp.4, 2011, https://doi.org/10.4236/wjns.2019.94022
  5. Role of corticotropin-releasing factor in alcohol and nicotine addiction vol.1740, pp.None, 2020, https://doi.org/10.1016/j.brainres.2020.146850